Viral Infections

  • Author: Jin S. Suh, MD, FACP; Humberto R. Jimenez, PharmD, BCPS, AAHIVP (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/26/16 (What's New)

Summary

  • Although PML incidence has decreased significantly since the widespread use of ART, PML has been reported in patients with HIV who have CD4+ cell counts > 300 cells/mm3 and as a complication of IRIS[Albrecht 1998]
  • Diagnosis of PML-IRIS should be considered in any person with HIV developing unexplained neurologic disorders or worsening of a previously diagnosed after the initiation or resumption of ART

Action required

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.